Pfizer to seek Japan COVID-19 vaccine approval for kids aged 5-11

U.S. pharmaceutical giant Pfizer Inc. is in talks with Japan to apply for approval to administer its COVID-19 vaccine to children aged 5 to 11, sources close to the matter said Wednesday.The revelation came a day after a U.S. Food and Drug Administration panel of independent experts voted in favor of issuing emergency use authorization for the vaccine to be administered to children in that age group.If submitted, Japan's Ministry of Health, Labor and Welfare plans to promptly review the application, according to the sources.Pfizer's COVID-19 vaccine, jointly developed with German partner Bi…READ FULL ARTICLE